IFP Advisors’s DMK Pharmaceuticals Corporation Common Stock DMK Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2021
Q3 | – | Hold |
0
| – | – | – | 4810 |
|
2021
Q2 | – | Hold |
0
| – | – | – | 4613 |
|
2021
Q1 | – | Hold |
0
| – | – | – | 4472 |
|
2020
Q4 | – | Hold |
0
| – | – | – | 4260 |
|
2020
Q3 | – | Hold |
0
| – | – | – | 4098 |
|
2020
Q2 | – | Hold |
0
| – | – | – | 3903 |
|
2020
Q1 | – | Hold |
0
| – | – | – | 3795 |
|
2019
Q4 | – | Sell |
-21
| Closed | -$1K | – | 3744 |
|
2019
Q3 | $1K | Buy |
+21
| New | +$1K | ﹤0.01% | 2948 |
|
2019
Q1 | – | Sell |
-21
| Closed | -$3K | – | 3545 |
|
2018
Q4 | $3K | Hold |
21
| – | – | ﹤0.01% | 3035 |
|
2018
Q3 | $5K | Hold |
21
| – | – | ﹤0.01% | 3202 |
|
2018
Q2 | $5K | Hold |
21
| – | – | ﹤0.01% | 3248 |
|
2018
Q1 | $6K | Hold |
21
| – | – | ﹤0.01% | 3107 |
|
2017
Q4 | $6K | Sell |
21
-1
| -5% | -$286 | ﹤0.01% | 3104 |
|
2017
Q3 | $8K | Sell |
22
-470
| -96% | -$171K | ﹤0.01% | 3142 |
|
2017
Q2 | $179K | Buy |
492
+471
| +2,243% | +$171K | 0.01% | 1188 |
|
2017
Q1 | $6K | Hold |
21
| – | – | ﹤0.01% | 3199 |
|
2016
Q4 | $5K | Sell |
21
-14
| -40% | -$3.33K | ﹤0.01% | 3310 |
|
2016
Q3 | $8K | Buy |
35
+14
| +67% | +$3.2K | ﹤0.01% | 2983 |
|
2016
Q2 | $4K | Buy |
+21
| New | +$4K | ﹤0.01% | 3269 |
|